Ma, Chaoqun
Ren, Xiaolei
Pang, Ning
Liu, Yingkun
Chen, Meifang
Zhang, Xiaohong
Liu, Yi
Huang, Lin
Funding for this research was provided by:
Bethune Charitable Foundation of Pharmaceutical Research Capacity Building Project (B-19-H-20200622)
Article History
Received: 4 March 2024
Accepted: 29 August 2024
First Online: 10 September 2024
Declarations
:
: This study was approved by Medical Ethics Committee of Peking University People’s Hospital (Beijing, China, IRB number 2023PHB294-001). Written informed consent from the participants’ legal guardian/next of kin was not required to participate in this retrospective study in accordance with the national legislation and the institutional requirements.
: We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
: The authors declare no competing interests.
: The full article was not posted or published elsewhere.